Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immediate Post Placental Insertion of Intrauterine Device at Cesarean Delivery, is Acceptable, Feasible and Safe in Iraqi Women.

NCT04136613 is registered in ClinicalTrials.gov with Taghreed Alhaidari as lead sponsor.

NCT NCT04136613
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04136613 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immediate Post Placental Insertion of Intrauterine Device at Cesarean Delivery, is Acceptable, Feasible and Safe in Iraqi Women.
Lead sponsor
Taghreed Alhaidari
Phase
Not applicable
Overall status
Completed
Start date
September 1, 2015
Completion date
June 1, 2019
Enrollment
150 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

contraception behavior